Enhabit Q1 revenue $265.1M, Adj EBITDA down 46% YoY; reaffirms FY guidance

Enhabit, Inc.

2023-Q1 EPS reported $0.05 revenue$265,100,000

Q1 net service revenue $265.1M (-3.4% YoY); net income $3.2M ($0.05 EPS), adjusted EPS $0.09 vs $0.56 prior.
Adjusted EBITDA $25.3M (9.5% margin) vs $47M (17.1%) YoY; shift to non-episodic and sequestration hurt revenue ~$10M.
Home health admissions up 1.2% YoY on 31.9% surge in non-episodic admissions; hospice admissions down 3.8% YoY.
New national Medicare Advantage payor agreement and two convener agreements effective May 1, 2023.
Full-year 2023 guidance reaffirmed: revenue $1.11-1.14B, Adj EBITDA $125-140M, adjusted EPS $0.50-$0.89.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Enhabit, Inc. updated its the first quarter ended March 31, 2023 guidance (reaffirmed).

Period: the first quarter ended March 31, 2023
Guidance: reaffirmed
Result: reported results

Exact text from the filing

On May 9, 2023, Enhabit, Inc. (the “Company”) issued a press release reporting the financial results of the Company for the quarter ended March 31, 2023.

View on SEC.gov

51 earnings releases filed in the last 30 days. Browse all earnings releases →

Enhabit, Inc. filing history →

Source: SEC EDGAR

accession 0001803737-23-000075

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.